“Fewer than 1% of patients taking the drug needed to be hospitalized and no one died. In the comparison group, 7% were hospitalized and there were seven deaths.” So promising that they halted the trial early. Pfizer, like Merck, *must* allow cheap generics for LMIC. No excuses.https://twitter.com/AP/status/1456576002457575427 …
-
Show this thread
-
I see some making fun this development, comparing pills to vaccines, “will they take it, it’s not horse dewormer.”
Folks! Not everyone responds well to vaccines—millions of immunocompromised people, to start with. It’s an unalloyed good to have more tools. This is great news!27 replies 117 retweets 1,261 likesShow this thread -
Replying to @zeynep
true. But if it induces many to avoid vaccine for no good reasons, it could be a net loss for us all. Public health is more than biochemistry.
2 replies 0 retweets 1 like
Replying to @Qbitzerre
It is, and hopefully it is more than making up weird second-order sociological effects without evidence or any reason to think they exist.
6:03 AM - 5 Nov 2021
1 reply
0 retweets
1 like
-
Show additional replies, including those that may contain offensive content
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.